As US payers and providers struggle with a fragmented healthcare system, patients with chronic conditions continue to experience gaps in their care. An AARP survey showed that a significant proportion of older adults experienced problems with their medical care, including…
Read
AllazoHealth Insights
Keep up with the latest insights and information on our blog. Find best practices, data and outcomes, and healthcare industry information, all from the experts and leaders at AllazoHealth.
Browse by topic
Subscribe to our news
Senior medication adherence: the growing problem
on March 8, 2021
| By
AllazoHealth
By the year 2030 the entire Baby Boomer generation will be age 65 or older. This growing number of senior Boomers will challenge the health care system, particularly when it comes to medication management and adherence. What are these challenges,…
Read
How payers and pharmacies can improve diabetes adherence
on March 1, 2021
| By
AllazoHealth
In the field of chronic diseases, Type 2 diabetes ranks high when it comes to the challenges of therapy initiation and non-adherence. Diabetes accounts for $24.6 billion in wasteful and avoidable healthcare spending in the United States, and almost 50%…
Read
Advances in patient interventions: How to manage complexity
on February 22, 2021
| By
AllazoHealth
Patient adherence programs are continually searching for more cost-effective interventions that improve clinical outcomes. Tactics have expanded beyond outreach by phone call to digital channels including emails and SMS text messages. In a trial of text and email interventions for…
Read
The challenge of mental health drug non-adherence
on February 15, 2021
| By
AllazoHealth
Major mental health disorders are some of the most difficult conditions to manage. According to a retrospective analysis in Systematic Reviews, almost 450 million people are affected by mental health disorders worldwide, contributing 14% of the overall global burden of…
Read
Overcoming medication adherence barriers in oral anticancer meds
on February 8, 2021
| By
AllazoHealth
Over the past decade, treatment in a variety of cancers, particularly breast cancer, chronic myelogenous leukemia, and non-small cell lung cancer, has switched from intermittent intravenous therapy to self-administered targeted oral anticancer medications (OAMs). There are more than 50 of…
Read
AllazoHealth now offers AI optimized therapy initiation
on February 1, 2021
| By
AllazoHealth
AllazoHealth continues to lead in advancing the use of artificial intelligence in healthcare. Building on our success in medication adherence, we have expanded our implementation of AI to include therapy initiation. Barriers to therapy initiation Therapy initiation is a critical…
Read
AllazoHealth names pharmaceutical industry analytics expert Mark Degatano to advisory board
on January 27, 2021
| By
AllazoHealth
AllazoHealth, a company that uses artificial intelligence to help pharmaceuticals, payers, and pharmacies improve medication adherence and quality outcomes, announced today that pharmaceutical industry veteran Mark Degatano will be joining the company’s Advisory Board. Mr. Degatano has over 35 years…
Read
Healthcare policy predictions for 2021
on January 18, 2021
| By
AllazoHealth
As the days tick down to the inauguration of President-elect Joseph Biden and Vice President-elect Kamala Harris, what will be the priorities of the new administration when it comes to U.S. healthcare? Let’s take a look. Handling the COVID-19 pandemic…
Read
Specialty drugs: the challenge of therapy initiation
on January 12, 2021
| By
AllazoHealth
AllazoHealth’s VP, Business Development Dev Mukherjee recently answered questions about specialty medications and the challenges faced by pharmaceutical companies and specialty drug pharmacies in regards to therapy initiation. What challenges do specialty drug patients experience? Dev: These medications can be…
Read
“Adherence Intelligence” is the new AI
on January 4, 2021
| By
AllazoHealth
How recognizing the unique characteristics of each patient optimizes resources and maximizes impact Medication non-adherence is an age-old problem that pharmaceutical companies have been grappling with for decades. According to industry research, the global pharmaceutical industry loses more than $600 billion a…
Read
current_page_num+2: 2 -